D-0582-2025 Class II Ongoing

Recalled by Westminster Pharmaceuticals LLC — Nashville, TN

FDA drug recall D-0582-2025 was initiated by Westminster Pharmaceuticals LLC on Aug 6, 2025 and is designated Class II. Reason for recall: CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level. The recall status is ongoing. Affected quantity: 4,456 1000-count bottles.

Recall details

Product Type
Drugs
Report Date
Aug 20, 2025
Initiation Date
Aug 6, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4,456 1000-count bottles

Product description

Metoprolol Tartrate Tablets, USP, 100 mg, 1000 Tablets, Rx Only, Manufactured by: Renata PLC (General Plant -2), Noyapara, Bhawal Mirzapur, Rajendrapur, Gazipur, 1700 Bangladesh, Distributed by: Westminster Pharmaceuticals, LLC, Nashville, TN 37217, NDC 69367-355-10

Reason for recall

CGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.

Distribution pattern

Nationwide in the USA.

Code information

Batch # R56240011, Exp Date: 2/28/26; Batch # R56240021, R56240031, Exp Date: 3/31/26; Batch # R56240041, R56240051, R56240061, Exp Date: 4/30/26; Batch # R56240071, Exp Date: 7/31/26

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0582-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0582-2025. Report a data issue: hello@regdatalab.com.